SCHEMBL852664

SCHEMBL852664

CCCC(CC(=O)OCC)c1c[nH]c2ccc(N)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
CYP2C19 P33261 2/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
THRA P10827 4/20 0.38
THRB P10828 4/20 0.38
GABRA1 P14867 2/20 0.37
GABRB2 P47870 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
KMT2A Q03164 1/20 0.37
TNF P01375 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRA3 P34903 1/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853777 0.87 GAA (0.43) KDM4EALDH1A1CYP2C19PKMHPGD
SCHEMBL8387335 0.83 PKM (0.55) KDM4EALDH1A1CYP2C19PKMGABRA1
SCHEMBL852764 0.83 HDAC3 (0.48) KDM4EMAPT
SCHEMBL853701 0.79 TRPM8 (0.55) KDM4EALDH1A1HTTHPGDGABRA1
SCHEMBL9672135 0.76 MTNR1A (0.53) KDM4EALDH1A1HTTCYP2C19HPGD
SCHEMBL5851341 0.75 GPR84 (0.62) ALDH1A1CYP2C19HPGDSMN1; SMN2CYP2D6
SCHEMBL6600034 0.74 PKM (0.67) KDM4EALDH1A1CYP2C19PKMHPGD
SCHEMBL852704 0.72 ITGB3 (0.45)
SCHEMBL6521138 0.71 GABRA1 (0.60) KDM4EALDH1A1CYP2C19HPGDGABRA1
SCHEMBL5791665 0.71 ALDH1A1 (0.47) ALDH1A1PKMTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed